Veracyte Gains 44% in a Year: What's Driving the Stock?

Veracyte (VCYT) has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 composite’s 24.4% gain.With a Zacks Rank #1 (Strong Buy) at present, the global diagnostics company is gaining more market shares from the strength of the Afirma solution. Veracyte is also making strides with the Decipher Prostrate test and advancing its long-term growth drivers, which are highly encouraging. Headquartered in San Francisco, CA ...